Clinical Trial Update: Prospective Clinical Performance Evaluation of the In-Vitro Diagnostics Medical Device MaGIA IBC for the CombIned screENing of HIV, Hepatitis B and Hepatitis C [NA]

View source ↗

Summary

Prospective clinical performance evaluation of the MaGIA IBC point-of-care device for combined screening of HIV, Hepatitis B, and Hepatitis C, currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis B
• Hepatitis C

Snippet

Sponsor: MagIA Diagnostics | Conditions: Combined Point of Care Diagnostic of HIV, HBV and HCV | NA | Status: RECRUITING